Overview
Hang Ding practices practicing medicine in Zhanjiang, China.
Her clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Nasopharyngeal Carcinoma, and Necrosis.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hang Ding
Is Hang Ding a top-rated expert for Acute Monoblastic Leukemia (AmoL)?
MediFind is an objective health platform that identifies experts based on real-world data. Hang Ding is classified as an Experienced expert for Acute Monoblastic Leukemia (AmoL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hang Ding participate in research or clinical trials?
Yes. Hang Ding has published 13 articles and abstracts on conditions like Acute Monoblastic Leukemia (AmoL). You can view a list of Hang Ding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Monoblastic Leukemia (AmoL)Ms. Ding isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Nasopharyngeal CarcinomaMs. Ding isExperienced. Learn about Nasopharyngeal Carcinoma.
- NecrosisMs. Ding isExperienced. Learn about Necrosis.